United States · FDA National Drug Code directory
Meropenem
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70121-1454_c346bc7b-a9e5-4669-bbf0-ea71912fd0fb
- Product NDC
- 70121-1454
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Meropenem
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160509
- Source listing expiry
- 20261231
Source-listed ingredients
- MEROPENEM — 500 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, GLASS in 1 CARTON (70121-1454-7) / 20 mL in 1 VIAL, GLASS (70121-1454-1) · 70121-1454-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →